Eris Lifesciences - Enhancing Broad Based Offerings In Derma: Prabhudas Lilladher

ERIS has announced to acquire nine derma brands of Dr. Reddy’s Labs for cash consideration of Rs 2.75 billion.

<div class="paragraphs"><p>Colourful pills. (Source:</p></div>
Colourful pills. (Source:
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.  
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More